GSK Registers Success in clinical trials of HIV Medicine
As per reports, it has been revealed that clinical trial for a novel AIDS medicine, being manufactured by GlaxoSmithKline and Shionogi, has proved to be quite effective.read more
View ArticleGood News for Eosinophilic Asthma Patients
There is good news for the patients of eosinophilic asthma.read more
View ArticleFDA Approves Raxibacumab
Food and Drug Administration (FDA) has give approval to Raxibacumab, a drug by GlaxoSmithKline which is expected to treat in inhalational anthrax.read more
View ArticleGSK Signs Agreement with Biological-E for Six-in-One Polio Vaccine
GlaxoSmithKline (GSK), the world's fourth largest drug maker, has entered into an equal joint venture agreement with Biological-E Ltd., a vaccines company based in Hyderabad, recently.read more
View ArticleFight against HIV; Introducing HIV Drugs For Poor Children
Today, about 3.4 million children have become the victim of HIV all over world and something worst to know about them is that 72% don't have enough access to appropriate care because the treatment...
View ArticleGSK Files for Albiglutide’s Approval
The European Medicines Agency (EMA) recently received a marketing authorization application (MAA) by pharmaceutical giant GlaxoSmithKline (GSK).read more
View ArticleGSK May Face Sooner-than-Expected Generic Competition
Draft guidance has newly been issued by the US Food and Drug Administration in a stumbling block to GlaxoSmithKline GSK -0.08%.read more
View ArticleDrug to Work against Neurodegenerative Disease in Experimental Stage
It has been said that GlaxoSmithKline is working on a drug that can work quite well against the neurodegenerative problems like Alzheimer's, Parkinson's disease.read more
View ArticleParents Warn to Use Panadol Dosing Device for their Children
Parents are being advised to immediately take children to hospitals, who had given Panadol dosing device to their children.read more
View ArticleGSK Applying for Regulatory Approval of World’s First Malaria Vaccine
GlaxoSmithKline (GSK. L) has developed the world's first vaccine against malaria. The vaccine will be used for children in Africa.read more
View Article